热门资讯> 正文

硕腾公司有条件批准Dectomax-CA 1用于牛寄生虫感染

2025-10-01 05:34

硕腾(ZTS) 0
Xtrackers California Municipal Bonds ETF(CA) 0
摩根士丹利(MS) 0

The US FDA has given conditional approval to Dectomax-CA1 (doramectin), an injection to treat New World screwworm myiasis in cattle.
The infection is caused by larvae of the new world screwworm fly feeding on the flesh of animals.
Although New World screwworm was eradicated in the US in 1966, Zoetis said that there is a constant risk of re-introduction.

More on Zoetis

Zoetis: Pet Pain Spells Potential Further Gains, But Valuation Suggests A Hold
Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Zoetis: A Solid Dividend Growth Investment For The Long Haul
Zoetis prices $1.85B senior notes
Zoetis raises 2025 organic operational revenue growth guidance to up to 8% while advancing key franchises

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。